Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1571 to 1580 of 2529

TitleReference numberPublishedLast updated
Oesophago-gastric cancer: assessment and management in adultsNG83
Ofatumumab for treating relapsing multiple sclerosisTA699
Off-pump coronary artery bypass graftingHTG249
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapyTA886
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapyTA962
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapyTA908
Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancerTA887
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapyTA1040
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancerTA951

Results per page

  1. 10
  2. 25
  3. 50
  4. All